GI-5005 THERAPEUTIC VACCINE PLUS PEG-IFN/RIBAVIRIN IMPROVES SUSTAINED VIROLOGIC RESPONSE VERSUS PEG-IFN/RIBAVIRIN IN PRIOR NON-RESPONDERS WITH GENOTYPE 1 CHRONIC HCV INFECTION

被引：0

作者：

Pockros, Paul ^{[1
]}

Jacobson, Ira ^{[2
]}

Boyer, Thomas D. ^{[3
]}

Schiff, Eugene R. ^{[4
]}

Everson, Gregory T. ^{[5
]}

Lee, William M. ^{[6
]}

Vierling, John M. ^{[7
,8
]}

Lawitz, Eric ^{[9
]}

Kugelmas, Marcelo ^{[10
,11
]}

Tsai, Naoky ^{[12
]}

Shiffman, Mitchell L. ^{[13
]}

Brown, Robert S. ^{[14
]}

Armstrong, Brian R. ^{[15
]}

Mattson, Alicia ^{[16
]}

Rodell, Timothy C. ^{[16
]}

Apelian, David ^{[16
]}

机构：

[1] Scripps Clin, La Jolla, CA 92037 USA

[2] Weill Cornell Med Coll, Ctr Study Hepatitis C, New York, NY USA

[3] Univ Arizona, Coll Med, Dept Med, Tucson, AZ USA

[4] Univ Miami, Sch Med, Ctr Liver Dis, Miami, FL USA

[5] Univ Colorado Denver, Dept Med, Aurora, CO USA

[6] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA

[7] Baylor Coll Med, Dept Med & Surg, Houston, TX 77030 USA

[8] St Lukes Episcopal Hosp, Houston, TX 77030 USA

[9] Alamo Med Res, San Antonio, TX USA

[10] PC, S Denver Gastroenterol, Englewood, CO USA

[11] Swedish Med Ctr, Ctr Dis Liver & Pancreas, Englewood, CO 80110 USA

[12] Univ Hawaii, Honolulu, HI 96822 USA

[13] Liver Inst Virginia, Newport News, VA USA

[14] Columbia Univ, Coll Phys & Surg, New York, NY USA

[15] QST Consultat, Allendale, MI USA

[16] Globelmmune, Louisville, CO USA

来源：

HEPATOLOGY | 2010年 / 52卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LB-6

引用

页码：404A / 405A

页数：2

共 50 条

[11] Letter: pitavastatin supplementation of PEG-IFN/ribavirin improves sustained virological response against HCV
Yokoyama, S.
Kawakami, Y.
Chayama, K.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (04) : 443 - 444
[12] Factors affecting sustained virologic response in patients with chronic hepatitis C receiving Peg-IFN and ribavirin treatment
Ozden, K.
Ozkurt, Z.
Erol, S.
Parlak, M.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S132 - S133
[13] GI5005 IMMUNOTHERAPY PLUS PEG-IFN/RIBAVIRIN IN GENOTYPE I CHRONIC HEPATITIS C PATIENTS COMPARED TO PEG-IFN/RIBAVIRIN ALONE IN NAIVE AND NON-RESPONDER PATIENTS; PRELIMINARY RVR AND VIRAL KINETIC ANALYSIS FROM THE GI5005-02 PHASE 2 STUDY
McHutchison, John G.
Lawitz, Eric J.
Vierling, John M.
Everson, Gregory T.
Jacobson, Ira M.
Shiffman, Mitchell L.
Boyer, Thomas D.
Schiff, Eugene R.
Cruickshank, Scott
Rodell, Timothy C.
Apelian, David
HEPATOLOGY, 2008, 48 (04) : 1023A - 1024A
[14] Hepatitis C virus dynamics during induction with high PEG-IFN doses and ribavirin compared with low PEG-IFN doses plus ribavirin in naive patients with chronic hepatitis C, genotype 1
Sánchez-Avila, JE
Buti, M
Lurie, Y
Martell, M
Esteban, R
Guardia, J
JOURNAL OF HEPATOLOGY, 2001, 34 : 5 - 5
[15] Discrepancy in virological and biochemistry response of patients with chronic hepatitis HCV positive on treatment with PEG-IFN plus ribavirin
Marino, N
Blanc, P
Blè, C
Pierotti, P
Mazzotta, F
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2003, 17 (02): : 205 - 206
[16] Open, randomized, multicentre Italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART
Cargnel, A
Angeli, E
Mainini, A
Gubertini, G
Giorgi, R
Schiavini, M
Duca, P
ANTIVIRAL THERAPY, 2005, 10 (02) : 309 - 317
[17] Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients
Donato, C.
Cingolani, A.
Pinnetti, C.
De Luca, A.
JOURNAL OF HEPATOLOGY, 2010, 52 (02) : 306 - 307
[18] Early virological response in HIV/HCV co-infected patients to IFN or Peg-IFN plus ribavirin assessed by HCV RNA measurement
Payan, C.
Pivert, A.
Morand, P.
Fafi-Kremer, S.
Carrat, F.
Pol, S.
Cacoub, P.
Perronne, C.
Lunel, F.
JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S134 - S134
[19] SUSTAINED VIROLOGIC RESPONSE (SVR) FOLLOWING RG7128 1500MG BID/PEG-IFN/RBV FOR 28 DAYS IN HCV GENOTYPE 2/3 PRIOR NON-RESPONDERS
Gane, E. J.
Rodriguez-Torres, M.
Nelson, D. E.
Jacobson, I. M.
McHutchison, J. G.
Duca, A.
Hyland, R.
Hill, G.
Albanis, E.
Symonds, W. T.
Berrey, M. M.
JOURNAL OF HEPATOLOGY, 2010, 52 : S16 - S16
[20] Impact of double filtration plasmapheresis in combination with PEG-IFN and ribavirin in previous non responders: a longitudinal HCV kinetic analysis
Dahari, Harel
Rendina, Maria
Ramunni, Alfonso
Cotler, Scott J.
Perelson, Alan S.
Castellaneta, Nicola Maurizio
Castellaneta, Antonino
Zappimbulso, Marianna
Bringiotti, Roberto
Rizzi, Salvatore F.
Squicciarino, Annamaria
Francavilla, Antonio
Di Leo, Alfredo
HEPATOLOGY, 2012, 56 : 718A - 718A

← 1 2 3 4 5 →